The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway (Q45753821)

From Wikidata

Jump to navigation Jump to search

scientific article published in August 1998

Language	Label	Description	Also known as
English	The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway	scientific article published in August 1998

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9738948

The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9738948

0 references

0 references

0 references

0 references

cannabinoid receptor

0 references

Francisco Molina-Holgado

object named as

F Molina-Holgado

1

1 reference

ORCID Public Data File 2021

Eduardo Molina-Holgado

1 reference

ORCID Public Data File 2021

author name string

E Molina-Holgado

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9738948

C Guaza

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9738948

language of work or name

0 references

publication date

1 August 1998

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9738948

number of pages

4

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9738948

433

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9738948

1-2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9738948

139-142

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9738948

Effect of Theiler's murine encephalomyelitis virus and cytokines on cultured oligodendrocytes and astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900851-5

21 January 2018

Theiler's murine encephalomyelitis virus-binding activity on neural and non-neural cell lines and tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900851-5

21 January 2018

Interleukin-6 production by brain tissue and cultured astrocytes infected with Theiler's murine encephalomyelitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900851-5

21 January 2018

IL-6 and APPs: anti-inflammatory and immunosuppressive mediators

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900851-5

21 January 2018

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900851-5

21 January 2018

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900851-5

21 January 2018

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900851-5

21 January 2018

Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900851-5

21 January 2018

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900851-5

21 January 2018

Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900851-5

21 January 2018

Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900851-5

21 January 2018

Anandamide suppresses nitric oxide and TNF-alpha responses to Theiler's virus or endotoxin in astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900851-5

21 January 2018

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900851-5

21 January 2018

Central nervous system cytokine mRNA expression following Theiler's murine encephalomyelitis virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900851-5

21 January 2018

Interleukin 6 production in the central nervous system during experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900851-5

21 January 2018

A second endogenous cannabinoid that modulates long-term potentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900851-5

21 January 2018

Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900851-5

21 January 2018

Receptors for B cell stimulatory factor 2. Quantitation, specificity, distribution, and regulation of their expression

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900851-5

21 January 2018

Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900851-5

21 January 2018

Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900851-5

21 January 2018

Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900851-5

7 January 2021

Influence of fatty acid ethanolamides and Δ9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2900851-5

7 January 2021

Identifiers

10.1016/S0014-5793(98)00851-5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9738948

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9738948

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45753821&oldid=2081011617"